Although the modulation of polarization markers by anti-TNF agents was similar in RA patients and controls, decrease in CD40 was observed with a greater extent in RA patients and increase in CD16 was observed with a greater extent in controls. This evidence concerns the gene CD40 and rheumatoid arthritis.